SCHEMBL9256748

SCHEMBL9256748

COc1ccc(CN2CCN(C(=S)SC)CC2)c(O)c1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.49
CHRM2 P08172 2/20 0.46
OPRK1 P41145 2/20 0.46
CPT1B Q92523 1/20 0.46
CYP1A2 P05177 1/20 0.46
SLC6A4 P31645 1/20 0.46
OPRD1 P41143 1/20 0.46
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 2/20 0.46
HTT P42858 2/20 0.46
PKM P14618 1/20 0.46
APOBEC3A P31941 1/20 0.45
CTDSP1 Q9GZU7 1/20 0.45
APOBEC3G Q9HC16 1/20 0.45
MEN1 O00255 7/20 0.44
KMT2A Q03164 7/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 2/20 0.43
BCHE P06276 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9255254 0.99 CYP2C19 (0.48) CYP2C19CHRM2OPRK1CPT1BCYP1A2
SCHEMBL9252776 0.90 CYP2C19 (0.60) CYP2C19CHRM2OPRK1CPT1BCYP1A2
Hydrochloric Acid SCHEMBL9249587 0.89 CYP2C19 (0.59) CYP2C19CHRM2OPRK1CPT1BCYP1A2
SCHEMBL9254016 0.84 KDM4E (0.58) CYP2C19ALDH1A1KDM4EHTTMEN1
SCHEMBL9252788 0.84 KMT2A (0.55) ALDH1A1KDM4EHTTMEN1KMT2A
SCHEMBL9821357 0.82 CYP2C19 (0.62) CYP2C19CHRM2OPRK1CPT1BCYP1A2
SCHEMBL9252507 0.81 CYP2C19 (0.46) CYP2C19CHRM2OPRK1CPT1BCYP1A2
SCHEMBL7758530 0.80 GAA (0.57) CYP2C19CHRM2OPRK1CYP1A2SLC6A4
SCHEMBL8947821 0.80 MEN1 (0.61) CYP2C19CHRM2OPRK1CPT1BCYP1A2
SCHEMBL9253004 0.80 LMNA (0.58) ALDH1A1KDM4EHTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5446146-A Treatment of liver disorders NIPPON CHEMIPHAR CO., LTD. (JP) 1995-08-29 US disclosed
EP-0326379-B1 Therapeutic agent for liver disease and piperazine derivatives NIPPON CHEMIPHAR CO (JP) 1994-06-01 EP disclosed
US-5070089-A INHIBITION OF LIPID PEROXIDATION NIPPON CHEMIPHAR CO., LTD. (JP) 1991-12-03 US disclosed
EP-0326379-A2 Therapeutic agent for liver disease and piperazine derivatives NIPPON CHEMIPHAR CO., LTD. (JP) 1989-08-02 EP disclosed